Recommendations on the management of meningioma and sex hormone therapy: The results of a collaborative effort between neurosurgical, endocrine and gynecological societies

Introduction: Exogenous and endogenous sex hormones, especially Progesterone agonists, may be causally linked to meningioma progression. Cessation of treatment leads to stabilization or regression of Progestin-induced meningioma. In many cases, avoiding sex hormone therapy may be possible in the con...

Full description

Saved in:
Bibliographic Details
Main Authors: Gilles Reuter, Iulia Potorac, Carlien de Herdt, Linda Ameryckx, Géraldine Brichant, Sébastien Froelich, Bertrand Baussart, Steven De Vleeschouwer, Tomas Menovsky, Tony Van Havenberghe, Patrice Finet, Michael Bruneau, Axelle Pintiaux
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Brain and Spine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772529424014103
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850053557202452480
author Gilles Reuter
Iulia Potorac
Carlien de Herdt
Linda Ameryckx
Géraldine Brichant
Sébastien Froelich
Bertrand Baussart
Steven De Vleeschouwer
Tomas Menovsky
Tony Van Havenberghe
Patrice Finet
Michael Bruneau
Axelle Pintiaux
author_facet Gilles Reuter
Iulia Potorac
Carlien de Herdt
Linda Ameryckx
Géraldine Brichant
Sébastien Froelich
Bertrand Baussart
Steven De Vleeschouwer
Tomas Menovsky
Tony Van Havenberghe
Patrice Finet
Michael Bruneau
Axelle Pintiaux
author_sort Gilles Reuter
collection DOAJ
description Introduction: Exogenous and endogenous sex hormones, especially Progesterone agonists, may be causally linked to meningioma progression. Cessation of treatment leads to stabilization or regression of Progestin-induced meningioma. In many cases, avoiding sex hormone therapy may be possible in the context of meningioma treatment. However, hormonal treatment is not always easily replaceable and concise real-world recommendations regarding sex hormones and meningioma are lacking. Material and methods: A combined effort was initiated between Neurosurgical, Gynaecological and Endocrinological societies of Belgium to gather relevant information regarding sex hormone therapies and meningioma. After complete literature review, consensual recommendations were established. Results: Collegial recommendations regarding sex hormones therapies and meningioma in the context of oral contraceptives, menopause hormonal treatment, fertility treatment, pregnancy and gender-affirming therapies are emitted and nuanced. Discussion and conclusion: Withdrawal and monitoring of sex hormone therapies are discussed in detail.A decision tree regarding Meningioma and Combined contraception, Progestin Contraception, Menopause Hormonal treatment, Progestin and Gender-affirming therapy is suggested.
format Article
id doaj-art-7f7514be26bc403f9d6bafb47344fa65
institution DOAJ
issn 2772-5294
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Brain and Spine
spelling doaj-art-7f7514be26bc403f9d6bafb47344fa652025-08-20T02:52:30ZengElsevierBrain and Spine2772-52942025-01-01510415410.1016/j.bas.2024.104154Recommendations on the management of meningioma and sex hormone therapy: The results of a collaborative effort between neurosurgical, endocrine and gynecological societiesGilles Reuter0Iulia Potorac1Carlien de Herdt2Linda Ameryckx3Géraldine Brichant4Sébastien Froelich5Bertrand Baussart6Steven De Vleeschouwer7Tomas Menovsky8Tony Van Havenberghe9Patrice Finet10Michael Bruneau11Axelle Pintiaux12Corresponding author.; Department of Neurosurgery, CHU de Liege, Liège, BelgiumDepartment of Endocrinology, CHU de Liege, Liège, BelgiumDepartment of Endocrinology, UZ Antwerpen, Antwerpen, BelgiumDepartment of Gynecology, UZ Antwerpen, Antwerpen, BelgiumDepartment of Gynecology, CHU de Liege, Liège, BelgiumDepartment of Neurosurgery, Hopital Lariboisiere, Paris, FranceDepartment of Neurosurgery, Hopital Lariboisiere, Paris, FranceDepartment of Neurosurgery, UZ Leuven, Leuven, BelgiumDepartment of Neurosurgery, UZ Antwerpen, Antwerpen, BelgiumDepartment of Neurosurgery, ZAS, Antwerpen, BelgiumDepartment of Neurosurgery, UCL Saint Luc, Brussels, BelgiumDepartment of Neurosurgery, UZ Brussels, Brussels, BelgiumDepartment of Gynecology, CHU de Liege, Liège, BelgiumIntroduction: Exogenous and endogenous sex hormones, especially Progesterone agonists, may be causally linked to meningioma progression. Cessation of treatment leads to stabilization or regression of Progestin-induced meningioma. In many cases, avoiding sex hormone therapy may be possible in the context of meningioma treatment. However, hormonal treatment is not always easily replaceable and concise real-world recommendations regarding sex hormones and meningioma are lacking. Material and methods: A combined effort was initiated between Neurosurgical, Gynaecological and Endocrinological societies of Belgium to gather relevant information regarding sex hormone therapies and meningioma. After complete literature review, consensual recommendations were established. Results: Collegial recommendations regarding sex hormones therapies and meningioma in the context of oral contraceptives, menopause hormonal treatment, fertility treatment, pregnancy and gender-affirming therapies are emitted and nuanced. Discussion and conclusion: Withdrawal and monitoring of sex hormone therapies are discussed in detail.A decision tree regarding Meningioma and Combined contraception, Progestin Contraception, Menopause Hormonal treatment, Progestin and Gender-affirming therapy is suggested.http://www.sciencedirect.com/science/article/pii/S2772529424014103MeningiomaProgestinOral contraceptiveMenopauseSex hormone therapy
spellingShingle Gilles Reuter
Iulia Potorac
Carlien de Herdt
Linda Ameryckx
Géraldine Brichant
Sébastien Froelich
Bertrand Baussart
Steven De Vleeschouwer
Tomas Menovsky
Tony Van Havenberghe
Patrice Finet
Michael Bruneau
Axelle Pintiaux
Recommendations on the management of meningioma and sex hormone therapy: The results of a collaborative effort between neurosurgical, endocrine and gynecological societies
Brain and Spine
Meningioma
Progestin
Oral contraceptive
Menopause
Sex hormone therapy
title Recommendations on the management of meningioma and sex hormone therapy: The results of a collaborative effort between neurosurgical, endocrine and gynecological societies
title_full Recommendations on the management of meningioma and sex hormone therapy: The results of a collaborative effort between neurosurgical, endocrine and gynecological societies
title_fullStr Recommendations on the management of meningioma and sex hormone therapy: The results of a collaborative effort between neurosurgical, endocrine and gynecological societies
title_full_unstemmed Recommendations on the management of meningioma and sex hormone therapy: The results of a collaborative effort between neurosurgical, endocrine and gynecological societies
title_short Recommendations on the management of meningioma and sex hormone therapy: The results of a collaborative effort between neurosurgical, endocrine and gynecological societies
title_sort recommendations on the management of meningioma and sex hormone therapy the results of a collaborative effort between neurosurgical endocrine and gynecological societies
topic Meningioma
Progestin
Oral contraceptive
Menopause
Sex hormone therapy
url http://www.sciencedirect.com/science/article/pii/S2772529424014103
work_keys_str_mv AT gillesreuter recommendationsonthemanagementofmeningiomaandsexhormonetherapytheresultsofacollaborativeeffortbetweenneurosurgicalendocrineandgynecologicalsocieties
AT iuliapotorac recommendationsonthemanagementofmeningiomaandsexhormonetherapytheresultsofacollaborativeeffortbetweenneurosurgicalendocrineandgynecologicalsocieties
AT carliendeherdt recommendationsonthemanagementofmeningiomaandsexhormonetherapytheresultsofacollaborativeeffortbetweenneurosurgicalendocrineandgynecologicalsocieties
AT lindaameryckx recommendationsonthemanagementofmeningiomaandsexhormonetherapytheresultsofacollaborativeeffortbetweenneurosurgicalendocrineandgynecologicalsocieties
AT geraldinebrichant recommendationsonthemanagementofmeningiomaandsexhormonetherapytheresultsofacollaborativeeffortbetweenneurosurgicalendocrineandgynecologicalsocieties
AT sebastienfroelich recommendationsonthemanagementofmeningiomaandsexhormonetherapytheresultsofacollaborativeeffortbetweenneurosurgicalendocrineandgynecologicalsocieties
AT bertrandbaussart recommendationsonthemanagementofmeningiomaandsexhormonetherapytheresultsofacollaborativeeffortbetweenneurosurgicalendocrineandgynecologicalsocieties
AT stevendevleeschouwer recommendationsonthemanagementofmeningiomaandsexhormonetherapytheresultsofacollaborativeeffortbetweenneurosurgicalendocrineandgynecologicalsocieties
AT tomasmenovsky recommendationsonthemanagementofmeningiomaandsexhormonetherapytheresultsofacollaborativeeffortbetweenneurosurgicalendocrineandgynecologicalsocieties
AT tonyvanhavenberghe recommendationsonthemanagementofmeningiomaandsexhormonetherapytheresultsofacollaborativeeffortbetweenneurosurgicalendocrineandgynecologicalsocieties
AT patricefinet recommendationsonthemanagementofmeningiomaandsexhormonetherapytheresultsofacollaborativeeffortbetweenneurosurgicalendocrineandgynecologicalsocieties
AT michaelbruneau recommendationsonthemanagementofmeningiomaandsexhormonetherapytheresultsofacollaborativeeffortbetweenneurosurgicalendocrineandgynecologicalsocieties
AT axellepintiaux recommendationsonthemanagementofmeningiomaandsexhormonetherapytheresultsofacollaborativeeffortbetweenneurosurgicalendocrineandgynecologicalsocieties